The T-SPOT®.PRT (Panel of Reactive T cells) test is available now as a CE-marked kit in the EU, and will soon be available in the UK as a testing service from our UK Oxford Diagnostic Laboratories.

In transplant, understanding the likelihood of a rejection event is an important factor in patient management. A T cell immune response to the donated organ can lead to T cell mediated rejection (TCMR), which is a complication detrimental to the survival of the organ. The T-SPOT.PRT test measures a transplant candidate’s T cell mediated response to cells representing the potential donor population. This test may help clinicians identify patients at increased risk of TCMR, which in turn may guide decisions regarding immunosuppressive therapies. Studies are underway to assess the relationship of pre-transplant T-SPOT.PRT test response to post-transplant outcomes.

For more information please email PRTinfo-EU@oxfordimmunotec.com or call +44 (0) 1235 442628.

T-SPOT and the Oxford Diagnostic Laboratories are registered trademarks of Oxford Immunotec Ltd.